Literature DB >> 17593041

Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.

Vittal Sree Rama Rao1, Jainudeen K A Jameel, Tapan K Mahapatra, Penelope L McManus, John N Fox, Philip J Drew.   

Abstract

As breast cancer is the most frequent cancer in the elderly with a peak incidence of 1 in 10 by the age of 80, it is important to establish optimum therapy in this group. We conducted a case note-based retrospective study of all elderly primary breast cancer patients aged 80 and above between 1992 and 2002. The type of treatment, complications, disease progression, recurrence, and overall survival were recorded. In all 110 patients aged 80 and above were treated for primary breast cancer, with 32 patients having advanced disease. Of these, 62 patients received primary endocrine treatment. 48 patients underwent surgery with 30 patients undergoing mastectomy. At follow-up, 34 patients suffered disease progression in the primary endocrine treatment group and three patients had local recurrence in the surgical group. The Kaplan-Meier analysis revealed significantly better survival in the surgical treatment group when compared with the primary endocrine treatment group, both in the early disease (n = 41; median survival: 71 months; compared to n = 37; median survival: 42 months; p = 0.0002) and the advanced disease (n = 7; median survival: 48 months; compared to n = 25; median survival: 36 months; p = 0.03). Prompt surgery and adjuvant treatment can decrease relapse and improve survival even in patients older than 80 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593041     DOI: 10.1111/j.1524-4741.2007.00444.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  5 in total

1.  Breast cancer in elderly women (≥ 80 years): variation in standard of care?

Authors:  Amy Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Julie A Margenthaler
Journal:  J Surg Oncol       Date:  2010-11-23       Impact factor: 3.454

2.  Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.

Authors:  Yang Luo; Yue Zhang; Yu-Xin Wu; Han-Bing Li; Di Shen; Yi-Qun Che
Journal:  J Clin Lab Anal       Date:  2021-12-11       Impact factor: 2.352

3.  Outcomes of a Geriatric Liaison Intervention to Prevent the Development of Postoperative Delirium in Frail Elderly Cancer Patients: Report on a Multicentre, Randomized, Controlled Trial.

Authors:  Liesbeth Hempenius; Joris P J Slaets; Dieneke van Asselt; Geertruida H de Bock; Theo Wiggers; Barbara L van Leeuwen
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

4.  Adherence to hormone therapy among women with breast cancer.

Authors:  Claudia Brito; Margareth Crisóstomo Portela; Mauricio Teixeira Leite de Vasconcellos
Journal:  BMC Cancer       Date:  2014-06-03       Impact factor: 4.430

Review 5.  Narrative review of immunotherapy and radiation therapy in elderly patients.

Authors:  Brittney Chau; Jonnby LaGuardia; Caressa Hui; Linda Ye; Yan Xing; Erminia Massarelli; Arya Amini
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.